Revenue
2017
2018
2019
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €153.51B | €156.88B | €189.54B | €179.59B | €149.42B | €58.99B | €110.41B | €105.73B | €105.80B | €110.59B |
| Research & development | €11.14B | €5.78B | €5.62B | €5.20B | €4.49B | €2.57B | €3.05B | €2.90B | €2.93B | €2.86B |
| Operating income | −€26.25B | €3.69B | €22.38B | €20.28B | €15.86B | €3.65B | — | — | — | — |
| EBITDAderived | −€19.27B | €10.91B | €29.93B | €27.07B | €21.73B | €5.85B | — | — | — | — |
| Net income | −€22.37B | €5.47B | €18.60B | €16.80B | €14.20B | €3.20B | €3.61B | €3.49B | €1.80B | €334.0M |
| Basic EPSper diluted share | -€7.75 | €1.86 | €5.98 | €5.35 | €4.64 | €2.05 | €2.33 | €2.27 | €1.19 | €0.22 |
| Diluted EPSper diluted share | -€7.75 | €1.84 | €5.94 | €5.31 | €4.51 | €1.95 | €2.30 | €2.24 | €1.18 | €0.22 |